Loading...
•
Mar 31, 2024
Conmed Q1 2024 Earnings Report
Reported solid top- and bottom-line growth and margin expansion in Q1 2024.
Key Takeaways
CONMED Corporation reported solid financial results for the first quarter ended March 31, 2024, with expected top- and bottom-line growth and margin expansion. Full-year reported revenue is now expected to be between $1.330 billion and $1.355 billion, and adjusted diluted net earnings per share are expected to be in the range of $4.25 to $4.35.
Delivered expected top- and bottom-line growth.
Achieved margin expansion during the quarter.
Maintained a compelling and diverse portfolio.
Revised full-year revenue guidance to $1.330 billion to $1.355 billion due to currency headwinds.
Conmed
Conmed
Forward Guidance
CONMED Corporation now anticipates full-year reported revenue to range between $1.330 billion and $1.355 billion. The company projects full-year adjusted diluted net earnings per share to be in the range of $4.25 to $4.35.
Challenges Ahead
- Expects incremental revenue currency headwinds of approximately $10 million.
- Revised full-year reported revenue guidance to between $1.330 billion and $1.355 billion, compared to the prior guidance range of between $1.340 billion and $1.365 billion.
- Expects full-year adjusted diluted net earnings per share in the range of $4.25 to $4.35, compared to its prior range of $4.30 to $4.40.
- The adjusted diluted net earnings per share are impacted by incremental foreign currency headwinds.
- Unable to present a quantitative reconciliation of expected diluted net earnings per share to expected adjusted diluted net earnings per share as unable to predict with reasonable certainty and without unreasonable effort the impact and timing of acquisition, integration and other charges.